Fig. 1.
Percentages of best response to atezolizumab for patients with programmed death-ligand 1 (PD-L1) expression < 5% or unknown (blue line, n=29) and those with PD-L1 expression > 5% or higher (red line, n=21). IC, immune cell.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.